Krka

Krka's reported carbon emissions

Krka, headquartered in SI and operating within the Pharmaceutical Preparation Manufacturing industry, reported a total of approximately 598.7 million kg CO2e in 2024. This figure encompasses Scope 1, 2, and 3 emissions. For Scope 1, Krka emitted approximately 56.9 million kg CO2e. Scope 2 emissions, on a market-based approach, were approximately 17.1 million kg CO2e. The largest portion of Krka's emissions in 2024 came from Scope 3, totalling approximately 524.7 million kg CO2e. Key contributors to Scope 3 emissions included purchased goods and services, accounting for roughly 422.6 million kg CO2e, and employee commute at approximately 9.5 million kg CO2e. In 2023, Krka's Scope 1 emissions were approximately 59.0 million kg CO2e, with Scope 2 (market-based) emissions at approximately 15.0 million kg CO2e. Scope 3 emissions for 2023 were not fully disclosed, with purchased goods and services noted as a missing data point. Looking at historical data, Krka's Scope 1 and 2 emissions in 2022 were approximately 77.2 million kg CO2e, down from roughly 79.9 million kg CO2e in 2021. In 2020, Scope 1 and 2 emissions were approximately 73.3 million kg CO2e. Krka has set a reduction target to decrease its total GHG emissions (Scope 1 and Scope 2) by 11,270 tonnes CO2-eq by 2030, representing a 1.0% reduction target relative to a 2023 baseline.